- Record: found
- Abstract: not found
- Article: not found
Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy
Evandro de Azambuja ,
Lieveke Ameye ,
Marie Diaz ,
Sandrine Vandenbossche ,
Philippe Aftimos ,
Sara Bejarano Hernández ,
Chao Shih-Li ,
François Delhaye ,
Christian Focan ,
Nathalie Cornez ,
Anita Vindevoghel ,
Marc Beauduin ,
Marc Lemort ,
Marianne Paesmans ,
Thomas Suter ,
Martine Piccart-Gebhart
November 2015
November 2015
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Epirubicin-based chemotherapy improves the outcome of early breast cancer (BC) patients.
However, cardiotoxicity remains an important side effect.